Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Policy
Novartis TO START R&D in Shanghai
November 13, 2006
| A version of this story appeared in
Volume 84, Issue 46
Novartis will set up a new drug discovery research facility at the Zhangjiang Hi-Tech Park in Shanghai. Employing as many as 400 scientists, it will be among the largest foreign-owned drug discovery centers in China. The company plans to spend $100 million to establish the facility. This money will cover the cost of setting up a temporary R&D center that will begin operating in May 2007 as well as the construction of a more permanent facility with 38,000 m2 of floor space. The firm expects to find most of its scientific staff in the Shanghai area.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter